drugset / Trial / NCT06350890
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Phase 3
Completed
408 enrolled
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical study is to evaluate the efficacy and safety of Berberine Ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes, inadequately controlled with diet and exercise alone.
Timeline
- Start
- 2023-11-05
- Primary completion
- 2024-12-12
- Completion
- 2025-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | berberine ursodeoxycholate | Small molecule | 1000 mg | Oral |